Rajkumar Ganesan

Company: Amgen Inc.

Job title: Executive Director of Immunotherapeutics

Seminars:

Assessing the Advantages of Using Bispecific Antibodies to Target Specific Killing 12:30 pm

Balancing genetic engineering with manufacturing of gamma delta Vd2 cells Engineering for bispecific antibody secretion to enable interaction of other immune cells in the tumor microenvironment Engaging other immune cells using cross reactive T-cell engagersRead more

day: Conference Day Two - Morning Track A